We are monitoring the impact of COVID-19 on MEA Nuclear Medicine Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 103
Share on
Share on

Middle East & Africa Nuclear Medicine Market Research Report – Segmented By SPECT & PET, Application, Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Industry Analysis, Size, Share, Growth, Trends, Forecast (2021-2026)

Pulished: April, 2021
ID: 103
Pages: 134

MEA Nuclear Medicine Market Size & Growth (2021 to 2026)

The Middle East & Africa nuclear medicine market is estimated at USD 1.60 billion in 2021 and is expected to reach USD 4.24 billion by 2026, at a compound annual growth rate (CAGR) of 21.45%.

The rising prevalence of cancer is majorly driving the nuclear medicine market in MEA. Also, the proliferation of chronic disorders such as cardiovascular diseases is boosting the market growth. Furthermore, an increase in the prevalence of increasing population with the rise in the growing elderly population is significantly contributing to the various chronic diseases such as cancer, diabetes, cardiovascular diseases, and many more among the people in this region; however, the UAE accounts for 40 percent of deaths in cardiovascular diseases which is mainly due to increase in risk factors such as abdominal obesity, unhealthy lifestyle, physical inactivity, alcohol are the major causes that are driving the market for the nuclear medicine.

On the other hand, an increase in the advancements of the technology for developing and improving the treatment and medication procedures for treating the diseases and introducing new improved and efficient products in the market is expected to fuel the market growth. In addition, other factors such as raising awareness among the people about pre-diagnosing the diseases and the availability of the treatment in the market, and growing demand for nuclear medicine are expected to accelerate the market growth.

Furthermore, the increasing initiative and investment from government and non-government firms for research activities for developing new innovative techniques are the other factors expected to provide lucrative growth opportunities to the market growth.

However, the costs of equipment used for diagnostic and treating procedures are growing, restricting the market growth of nuclear medicine. In addition, the lack of skilled and trained individuals for performing diagnostic procedures and operating the equipment are the other factors that hamper the growth of the nuclear medicine market in this region. In furthermore, the approval process for nuclear treatments is lengthy and complicated. Additionally, strict government restrictions make product entrance more complex, limiting the expansion of the nuclear medicine industry. Besides that, poor reimbursement policies further hinder the market's growth.

This research report on the MEA Nuclear Medicine Market has been segmented and sub-segmented into the following categories:

By Type:

  • SPECT
  • PET

By Application:

  • Cardiology
  • Lymphoma
  • Thyroid
  • Neurology
  • Oncology
  • others

By Country:

  • KSA
  • UAE
  • Israel
  • rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

The middle east nuclear medicine market is expected to grow at a promising rate due to the increasing occurrence of Cancer and Cardiovascular Diseases in the region. Also, improving the healthcare sector, increasing healthcare spending, and supportive government policies propel the market growth.

 South Africa held the largest share of the medicine market, and it is anticipated to record a significant share during the forecast period. In addition, Africa has seen a spike in cancer as nuclear medicine is very effective in treating cancer and cardiovascular diseases. Thus, there is a high focus on research and development, resulting in new product introductions in the market.

Similarly, the UAE is more likely to witness a promising share during the forecast period due to government policies, technological advancements, and increasing research and development activities. However, the UAE has also experienced increased cancer patients in recent years, which has triggered the nuclear medicine market growth.

On the other hand, Saudi Arabia is projected to record a considerable share in the market as the country witnessed a significant increase in cardiovascular disease patients in recent years. In addition, the government has also been focusing on research and development of new nuclear drugs, contributing to market growth.

KEY MARKET PLAYERS:

Companies playing a leading role in the MEA Nuclear Medicine Market are Cardinal Health, Inc., Bracco Imaging S.p.A, GE Healthcare, Eczacibasi-Monrol Nuclear Products, Nordion, Inc., Bayer Healthcare, Lantheus Medical Imaging, Inc., Advanced Accelerator Applications S.A., IBA Molecular Imaging and Mallinckrodt plc.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Analysis Design                         

                2.3 Research Phases                      

                                2.3.1 Secondary Research            

                                2.3.2 Primary Research 

                                2.3.3 Econometric Modelling     

                                2.3.4 Expert Validation  

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments                

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 By Type                        

                                5.1.1 SPECT        

                                                5.1.1.1 Technetium-99m

                                                5.1.1.2 Thallium-201

                                                5.1.1.3 Gallium-67

                                                5.1.1.4 Iodine-23

                                                5.1.1.5 Others

                                5.1.2 PET             

                                                5.1.2.1 Fluorine-18

                                                5.1.2.2 Rubidium-82

                                                5.1.2.3 Others

                5.2 By Application                           

                                5.2.1 Cardiology               

                                5.2.2 Lymphoma             

                                5.2.3 Thyroid     

                                5.2.4 Neurology

                                5.2.5 Oncology 

                                5.2.6 Others      

6. Geographical Analysis                                              

                                6.5.1 UAE           

                                6.5.2 Saudi Arabia           

                                6.5.3 Israel         

                                6.5.4 South Africa            

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 GE Healthcare                           

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues            

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 Cardinal Health Inc.                 

                8.3 Bracco Imaging S.p.A                              

                8.4 Eczacibasi-Monrol Nuclear Products                

                8.5 Nordion, Inc.                              

                8.6 Bayer Healthcare                     

                8.7 Lantheus Medical Imaging, Inc.                          

                8.8 Advanced Accelerator Applications S.A.                         

                8.9 IBA Molecular Imaging                           

                8.10 Mallinckrodt plc.                    

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Expert Opinions                                         

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Middle East & Africa Nuclear Medicine Diagnostics Market By Region, From 2021 to 2026 (USD Billion)
  2. Middle East & Africa Nuclear Medicine Diagnostics Market By Type, From 2021 to 2026 (USD Billion)
  3. Middle East & Africa SPECT Diagnostic Radioisotopes Market By Region, From 2021 to 2026 (USD Billion)
  4. Middle East & Africa PET Diagnostic Radioisotopes Market By Region, From 2021 to 2026 (USD Billion)
  5. Middle East & Africa Nuclear Medicine Diagnostics Market By Application, From 2021 to 2026 (USD Billion)
  6. Middle East & Africa Cardiology Market By Region, From 2021 to 2026 (USD Billion)
  7. Middle East & Africa Lymphoma Market By Region, From 2021 to 2026 (USD Billion)
  8. Middle East & Africa Thyroid Market By Region, From 2021 to 2026 (USD Billion)
  9. Middle East & Africa Neurology Market By Region, From 2021 to 2026 (USD Billion)
  10. Middle East & Africa Oncology Market By Region, From 2021 to 2026 (USD Billion)
  11. Middle East & Africa Other Applications Market By Region, From 2021 to 2026 (USD Billion)
  12. Middle East & Africa SPECT Diagnostic Radioisotopes Market By Type, From 2021 to 2026 (USD Billion)
  13. Middle East & Africa Technetium-99m Market By Region, From 2021 to 2026 (USD Billion)
  14. Middle East & Africa Thallium-201 Market By Region, From 2021 to 2026 (USD Billion)
  15. Middle East & Africa Gallium-67 Market By Region, From 2021 to 2026 (USD Billion)
  16. Middle East & Africa Iodine-23 Market By Region, From 2021 to 2026 (USD Billion)
  17. Middle East & Africa Other SPECT Diagnostic Radioisotopes Market By Region, From 2021 to 2026 (USD Billion)
  18. Middle East & Africa PET Diagnostic Radioisotopes Market By Type, From 2021 to 2026 (USD Billion)
  19. Middle East & Africa Fluorine-18 Market By Region, From 2021 to 2026 (USD Billion)
  20. Middle East & Africa Rubidium-82 Market By Region, From 2021 to 2026 (USD Billion)
  21. Middle East & Africa Other PET Diagnostic Radioisotopes Market By Region, From 2021 to 2026 (USD Billion)
  22. UAE Nuclear Medicine Diagnostics Market By Type, From 2021 to 2026 (USD Billion)
  23. UAE Nuclear Medicine Diagnostics Market By Application, From 2021 to 2026 (USD Billion)
  24. Saudi Arabia Nuclear Medicine Diagnostics Market By Type, From 2021 to 2026 (USD Billion)
  25. Saudi Arabia Nuclear Medicine Diagnostics Market By Application, From 2021 to 2026 (USD Billion)
  26. Israel Nuclear Medicine Diagnostics Market By Type, From 2021 to 2026 (USD Billion)
  27. Israel Nuclear Medicine Diagnostics Market By Application, From 2021 to 2026 (USD Billion)
  28. South Africa Nuclear Medicine Diagnostics Market By Type, From 2021 to 2026 (USD Billion)
  29. South Africa Nuclear Medicine Diagnostics Market By Application, From 2021 to 2026 (USD Billion)
  30. UAE SPECT Diagnostic Radioisotopes Market By Type, From 2021 to 2026 (USD Billion)
  31. Saudi Arabia SPECT Diagnostic Radioisotopes Market By Type, From 2021 to 2026 (USD Billion)
  32. Israel SPECT Diagnostic Radioisotopes Market By Type, From 2021 to 2026 (USD Billion)
  33. South Africa SPECT Diagnostic Radioisotopes Market By Type, From 2021 to 2026 (USD Billion)
  34. UAE PET Diagnostic Radioisotopes Market By Type, From 2021 to 2026 (USD Billion)
  35. Saudi Arabia PET Diagnostic Radioisotopes Market By Type, From 2021 to 2026 (USD Billion)
  36. Israel PET Diagnostic Radioisotopes Market By Type, From 2021 to 2026 (USD Billion)
  37. South Africa PET Diagnostic Radioisotopes Market By Type, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample